BR0015425A - N-aryl- (homopiperazinyl) -cyclohexylamines as 5-ht carriers - Google Patents

N-aryl- (homopiperazinyl) -cyclohexylamines as 5-ht carriers

Info

Publication number
BR0015425A
BR0015425A BR0015425-3A BR0015425A BR0015425A BR 0015425 A BR0015425 A BR 0015425A BR 0015425 A BR0015425 A BR 0015425A BR 0015425 A BR0015425 A BR 0015425A
Authority
BR
Brazil
Prior art keywords
alkyl
aryl
carriers
carbon atoms
substitutable
Prior art date
Application number
BR0015425-3A
Other languages
Portuguese (pt)
Inventor
Adam Matthew Gilbert
Richard Eric Mewshaw
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0015425A publication Critical patent/BR0015425A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"N-ARIL-(HOMOPIPERAZINIL)-CICLOHEXILAMINAS COMO TRANSPORTADORAS DE 5-HT" A presente invenção refere-se a novos compostos e métodos e composições usando os mesmos no tratamento de distúrbios do sistema nervoso central, incluindo depressão e ansiedade, os compostos tendo a fórmula (I), em que Ar representa um grupo arila, arilalquila ou heteroarila; R~ 1~ e R~ 2~ são independentemente selecionados de hidrogênio, alquila de 1 a 12 átomos de carbono que pode ser substituído por cicloalquila de 3 a 10 átomos de carbono, que pode ser substituído; R~ 3~ é H, alquila que pode ser substituído, alquila cíclica que pode ser substituído, halogênio, alcóxi, haloalquila, OH, nitro, amino, CN, carbóxi, alcoxicarbonila, alquilcarbonila, aminocarbonila e alquilaminocarbonila, ou um sal farmaceuticamente aceitável dos mesmos."N-ARIL- (HOMOPIPERAZINIL) -CYCLEHEXYLAMINES AS 5-HT CARRIERS" The present invention relates to new compounds and methods and compositions using them in the treatment of central nervous system disorders, including depression and anxiety, compounds having formula (I), where Ar represents an aryl, arylalkyl or heteroaryl group; R ~ 1 ~ and R ~ 2 ~ are independently selected from hydrogen, alkyl of 1 to 12 carbon atoms which can be replaced by cycloalkyl of 3 to 10 carbon atoms, which can be substituted; R ~ 3 ~ is H, substitutable alkyl, substitutable cyclic alkyl, halogen, alkoxy, haloalkyl, OH, nitro, amino, CN, carboxy, alkoxycarbonyl, alkylcarbonyl, aminocarbonyl and alkylaminocarbonyl, or a pharmaceutically acceptable salt of themselves.

BR0015425-3A 1999-11-08 2000-05-19 N-aryl- (homopiperazinyl) -cyclohexylamines as 5-ht carriers BR0015425A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43612999A 1999-11-08 1999-11-08
PCT/US2000/014020 WO2001034597A1 (en) 1999-11-08 2000-05-19 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters

Publications (1)

Publication Number Publication Date
BR0015425A true BR0015425A (en) 2002-07-16

Family

ID=23731225

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015425-3A BR0015425A (en) 1999-11-08 2000-05-19 N-aryl- (homopiperazinyl) -cyclohexylamines as 5-ht carriers

Country Status (8)

Country Link
EP (1) EP1228064A1 (en)
JP (1) JP2003513969A (en)
CN (1) CN1420883A (en)
AU (1) AU5152300A (en)
BR (1) BR0015425A (en)
CA (1) CA2390530A1 (en)
MX (1) MXPA02004554A (en)
WO (1) WO2001034597A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103648D0 (en) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic quinolone compounds
SE0103649D0 (en) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic quinoline compounds
JP2007106746A (en) * 2005-09-13 2007-04-26 Tosoh Corp New aryl homopiperazine compounds, or their salt and production method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
CA2275299C (en) * 1996-12-20 2003-12-16 H. Lundbeck A/S Indane or dihydroindole derivatives

Also Published As

Publication number Publication date
WO2001034597A1 (en) 2001-05-17
AU5152300A (en) 2001-06-06
CN1420883A (en) 2003-05-28
JP2003513969A (en) 2003-04-15
CA2390530A1 (en) 2001-05-17
EP1228064A1 (en) 2002-08-07
MXPA02004554A (en) 2004-09-10

Similar Documents

Publication Publication Date Title
BRPI0507984B8 (en) compound or a salt thereof, process for making a compound, medicine, methods for antagonizing angiotensin ii in a mammal, for improving insulin resistance in a mammal and for preventing or treating circulatory diseases in a mammal, and, use of the compound
BR0215429A (en) Compound of formula I and its uses, activity inhibition methods and monoamine receptor activation inhibition method, treatment methods, genetic polymorphism identification method and patient identification method
BRPI0407976A (en) 2,5 and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators
EA200400466A1 (en) DERIVATIVES OF PIPERAZINE WITH ANTAGONISTIC ACTIVITY TO CCR1 RECEPTOR
BRPI0818193B8 (en) compound, pharmaceutical composition, and use of a compound
BR0317273A (en) Pharmaceutical uses for alpha2delta ligands
AP1822A (en) Substituted pyridinones as modulators of P38 MAP kinase.
TW200716084A (en) Methods for treating sleep-wake disorders
BRPI0509364A (en) tetrahydroquinoline derivatives and a process for preparing them
MX2010000617A (en) Compounds and methods for kinase modulation, and indications therefor.
TW200613306A (en) Imidazotriazines as protein kinase inhibitors
NO20062139L (en) Dihydrobenzofuranyl-alkanamine derivatives as 5HT2C agonists
BR0312999A (en) Compounds, pharmaceutical compositions, method for enhancing cognition, treatment, inhibiting pde4 enzyme activity in a patient
BRPI0518233A2 (en) adjunctive therapy for depression
BR9810829A (en) Compound, process for preparing the same, composition, use of a compound or a pharmaceutically acceptable salt thereof or a composition, and process for treating a condition
BR9808552A (en) Tricyclic compound or a pharmaceutically acceptable salt thereof, and pharmaceutical composition
BR0210733A (en) Useful piperidine derivatives useful as modulators of chemokine receptor activity
MY145066A (en) Methods for treating sexual dysfunction
BRPI0411285A (en) compound, process for preparing a compound pharmaceutical formulation, use of a compound, and method of preventing or treating disorders
BRPI0408591A (en) 8-substituted 6,7,8,9-tetrahydropyrime [1,2-a] pyrimidin-4-one derivatives
BRPI0406500A (en) pharmaceutical process and compounds prepared by it
BRPI0408248A (en) azabicyclic derivatives of pyridyloxymethyl and benzisoxazole
BRPI0414241A (en) compound, pharmaceutical composition, methods for activating 5-ht1f receptors in a mammal, inhibiting neuronal protein extravasation in a mammal, and treating or preventing migraine in a mammal, and, use of a compound
BR0015401A (en) [(indol-3-yl) -cycloalkyl] -3-substituted azetidines for the treatment of central nervous system disorders
BR0315837A (en) Heteroaryl hexanoic acid amide derivatives as immunomodulatory agents

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired